Ascension Via Christi Hospital Manhattain, Inc | |
1823 College Ave, Manhattan, Kansas 66502 | |
(785) 776-2831 | |
Name | Ascension Via Christi Hospital Manhattain, Inc |
---|---|
Type | Acute Care Hospital |
Location | 1823 College Ave, Manhattan, Kansas |
Ownership | Voluntary non-profit - Church |
Emergency Services | Yes |
Medicare ID (CCN) | 170142 |
NPI Number | 1760482517 |
Organization Name | ASCENSION VIA CHRISTI HOSPITAL MANHATTAN, INC. |
Address | 1823 College Ave, Manhattan, KS 66502 |
Hospital Type | General Acute Care Hospital |
Phone Number | 785-776-3322 |
News Archive
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Securities and Exchange Commission ("SEC") declared the Company's registration statement effective on February 9, 2010. The registration statement relates to the ordinary shares underlying warrants and certain other securities issued in connection with the initial public offering of Pantheon China Acquisition Corp.
Researchers have taken another crack at a promising approach to stopping Alzheimer's disease that encountered a major hurdle last year. In research published this week in the Journal of Clinical Investigation, scientists have developed a compound that targets a molecular actor known as RAGE, which plays a central role in mucking up the brain tissue of people with the disease.
The study reports the case of a 36 year old professional body-builder who required emergency care for chest pain.
› Verified 9 days ago
Able to receive lab results electronically | Yes |
Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
Scientists at The Scripps Research Institute (TSRI) have identified a set of compounds that may be used to treat multiple sclerosis (MS) in a new way. Unlike existing MS therapies that suppress the immune system, the compounds boost a population of progenitor cells that can in turn repair MS-damaged nerve fibers.
miRagen Therapeutics, Inc., a privately-held biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to the company's compound MGN-4893 for the treatment of polycythemia vera, a myeloproliferative disease characterized by an overabundance of blood cells and platelets in the body.
China Cord Blood Corporation, China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Securities and Exchange Commission ("SEC") declared the Company's registration statement effective on February 9, 2010. The registration statement relates to the ordinary shares underlying warrants and certain other securities issued in connection with the initial public offering of Pantheon China Acquisition Corp.
Researchers have taken another crack at a promising approach to stopping Alzheimer's disease that encountered a major hurdle last year. In research published this week in the Journal of Clinical Investigation, scientists have developed a compound that targets a molecular actor known as RAGE, which plays a central role in mucking up the brain tissue of people with the disease.
The study reports the case of a 36 year old professional body-builder who required emergency care for chest pain.
› Verified 9 days ago
Ascension Via Christi Hospital Manhattain, Inc Acute Care Hospital Location: 1823 College Ave, Manhattan, Kansas 66502 Phone: (785) 776-2831 | |
Manhattan Surgical Hospital Llc Acute Care Hospital Location: 1829 College Avenue, Manhattan, Kansas 66502 Phone: (785) 776-5100 |